Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
Karuna Kumar, Senior Consultant at Yashoda Hospitals, shared a post on LinkedIn about a recent article by Mamadou Bah published in The American Journal of Clinical Nutrition, adding:
“Interesting trial from Gambia on treating iron deficiency in children.
The problem:
- Ferrous sulfate tablets work poorly in kids with chronic inflammation.
- Poor absorption.
- GI upset.
- Low compliance.
This study tested heme iron polypeptide (HIP) against standard ferrous salts.
Heme iron is the form found in meat.
It absorbs through a different pathway than regular iron supplements.
Doesn’t get blocked by inflammation the same way.
The results?
Both raised hemoglobin. But heme iron had better tolerability and absorption in kids with high inflammation markers.
Why this matters for India:
We have millions of children with chronic infections, parasites, and subclinical inflammation.
Standard iron tablets often fail them.
Heme iron supplements exist but are underused. They cost more, yes. But if regular iron isn’t working after 2-3 months, it’s worth considering.
Not every anemia responds to the cheapest option. Sometimes you need to match the treatment to the patient.”
Title: Heme iron compared with ferrous iron salts to treat iron deficiency anemia in Gambian children: a randomized controlled trial
Authors: Mamadou Bah, Hans Verhoef, Emmanuel Okoh, Abdoulie Bah, Alhasan Colley, Alasana Saidykhan, Andrew M Prentice, Carla Cerami
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 14, 2026, 11:58Cesare Medri: A New Learning Achievement in Haemoglobin Disorder Care
-
Oct 14, 2026, 07:36Daniel Pereira Monteiro: ASCAT 2026 A Day of Science, Connection and Community
-
Oct 14, 2026, 07:20Rachael Jackman: Understanding Models of Transfusion Medicine at AABB 2026
-
Oct 14, 2026, 07:09Dianne E. van der Wal: A New Chapter in Academia Celebrating a Journey in Research, Teaching and Platelet Science
-
Oct 14, 2026, 06:55Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development
-
Oct 14, 2026, 06:37Neoklis Mparis: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome During Bridging Anticoagulation
-
Oct 14, 2026, 06:00Aymen A.: LAAC vs. OAC in Patients with Atrial Fibrillation Including CHAMPION-AF and CLOSURE-AF Trials
-
Oct 13, 2026, 21:05Francisco Chacón-Lozsán: Heparin-Induced Thrombocytopenia – When an Anticoagulant Triggers Thrombosis
-
Oct 13, 2026, 21:04Aref Zribi: Isolated Tumor Thrombus and the Role of Prophylactic Anticoagulation